Clinical development of imatinib: an anticancer drug

BACKGROUND: A novel and accurate high-throughput tandem mass spectroscopic method has been developed and validated for determination of imatinib, a protein-tyrosine kinase inhibitor against chronic myeloid leukemia. MATERIALS & METHODS: Chromatographic separation was carried on XTerra(®) RP18 co...

Descripción completa

Detalles Bibliográficos
Autores principales: Goswami, Dipanjan, Gurule, Sanjay, Lahiry, Abhiroop, Anand, Amit, Khuroo, Arshad, Monif, Tausif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137965/
https://www.ncbi.nlm.nih.gov/pubmed/28031942
http://dx.doi.org/10.4155/fso.15.92

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137965/
https://www.ncbi.nlm.nih.gov/pubmed/28031942
http://dx.doi.org/10.4155/fso.15.92

Ejemplares similares